Bausch Health Companies Inc
NYSE:BHC
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
5.22
10.61
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
Abbvie Inc
NYSE:ABBV
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Realty Income Corp
NYSE:O
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Wall Street
Price Targets
BHC Price Targets Summary
Bausch Health Companies Inc
According to Wall Street analysts, the average 1-year price target for BHC is 6.8 USD with a low forecast of 6.36 USD and a high forecast of 7.39 USD.
BHC Last Price Targets
Bausch Health Companies Inc
The latest public price target was made on Jul 25, 2024 by
Les Sulewski
from
Truist Financial
,
who expects
BHC
stock to
drop by 16%
over the next 12 months.
You can read more about this price target by viewing
the article on TheFly.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Les Sulewski
Truist Financial
|
7
USD
Downside 16% |
2 months ago
Jul 25, 2024
|
Bausch Health price target lowered to $7 from $8 at Truist
TheFly
|
Michael Freeman
Raymond James
|
8
USD
Downside 4% |
2 months ago
Jul 10, 2024
|
Bausch initiated with Market Perform on Xifaxan risk at Raymond James
TheFly
|
David Amsellem
Piper Sandler
|
9
USD
Upside 8% |
5 months ago
Apr 29, 2024
|
Bausch Health Companies (BHC) PT Raised to $9 at Piper Sandler
StreetInsider
|
Doug Miehm
RBC Capital
|
11
USD
Upside 32% |
5 months ago
Apr 23, 2024
|
Bausch Health Companies (BHC) PT Lowered to $11 at RBC Capital
StreetInsider
|
Glen Santangelo
Jefferies
|
16
USD
Upside 92% |
5 months ago
Apr 11, 2024
|
Jefferies on BHC (BHC): 'We see this as an extremely positive outcome for BHC and removes a key barrier to executing the spin'
StreetInsider
|
|
Doug Miehm
RBC Capital
|
12
USD
Upside 44% |
6 months ago
Apr 5, 2024
|
Bausch Health Companies (BHC) PT Raised to $12 at RBC Capital
StreetInsider
|
Price Targets
Operating Income
Forecast
Operating Income Estimate
Bausch Health Companies Inc
For the last 8 years the compound annual growth rate for Bausch Health Companies Inc's operating income is -4%. The projected CAGR for the next 3 years is 29%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is BHC's stock price target?
Price Target
6.8
USD
According to Wall Street analysts, the average 1-year price target for BHC is 6.8 USD with a low forecast of 6.36 USD and a high forecast of 7.39 USD.
What is Bausch Health Companies Inc's Revenue forecast?
Projected CAGR
5%
For the last 8 years the compound annual growth rate for Bausch Health Companies Inc's revenue is -2%. The projected CAGR for the next 3 years is 5%.
What is Bausch Health Companies Inc's Operating Income forecast?
Projected CAGR
29%
For the last 8 years the compound annual growth rate for Bausch Health Companies Inc's operating income is -4%. The projected CAGR for the next 3 years is 29%.
You don't have any saved screeners yet
